Goodwin Procter LLP advised SpringWorks Therapeutics (Nasdaq: SWTX) on its clinical trial collaboration agreement with Allogene Therapeutics, Inc. (Nasdaq: ALLO). The agreement will evaluate ALLO-715, Allogene’s…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now